Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique.

Hartwig FP, Davies NM, Hemani G, Davey Smith G. · 2016

Read Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique. by Hartwig FP, Davies NM, Hemani G, Davey Smith G. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5722032.txt.

Introduction

Hartwig and co-authors explain how to avoid common pitfalls in a genetic causal method. Their guide covers two-sample Mendelian randomization. The method uses genetic variants as stand-ins for a risk factor or exposure. It draws on summary results from two separate groups of people.

Such studies rose from none in 2011 to 42 percent of the field by 2016. The approach is powerful, but it rests on strict assumptions. Variants must link to the exposure and reach the outcome only through it. Sample overlap between the two groups can bias results. Weak instruments pose a further risk. The authors show how careful design can dodge these downsides.

Catalog record

CREATORHartwig FP, Davies NM, Hemani G, Davey Smith G.
YEAR2016
COLLECTIONPAPERS
FORMATTXT
FILE SIZE43 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5722032

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique By Fernando Pires Hartwig, Neil Martin Davies, Gibran Hemani, George Davey Smith Published in: International Journal of Epidemiology DOI: 10.1093/ije/dyx028 SUMMARY DATA AND TWO-SAMPLE MENDELIAN RANDOMIZATION Mendelian randomization studies are often performed in an instrumental variables framework, using germline genetic variants as instruments for modifiable disease risk factors or exposures.1–3 Mendelian randomization analysis depends on assuming that the genetic variants: (i) are associated with the exposure (the relevance assumption); (ii) have no common cause with the outcome (the independence assumption); and (iii) have effects on the outcome that are solely mediated by the exposure (the exclusion restriction assumption).1–3 Summary data Mendelian randomization refers to methods which use summary-level instrument-exposure and instrument-outcome association results (typically, per-allele regression coefficients and standard errors) to obtain causal effect estimates. Two-sample Mendelian randomization refers to the application of Mendelian randomization methods to summary association results estimated in non-overlapping sets of individuals. These data can be obtained from the published literature, typically from summary results provided by consortia of genome-wide association studies (GWAS), or estimated directly from individual-level participant data.4 Recent examples include studies evaluating the causal effects of adiposity-related traits on risk of breast, ovarian, prostate, lung and colorectal cancers,5 of body mass index on type 2 diabetes6 and of telomere length on several health outcomes.7 As with Mendelian randomization in general, two-sample Mendelian randomization is analogous to methods originally developed in econometrics.8,9 Recent developments in two-sample Mendelian randomization are based on methods originally developed for meta-analysis.10,11 Whereas the first formal extended elucidation of Mendelian randomization contained what are in essence two-sample Mendelian randomization estimates (e.g. of the influence of homocysteine on coronary heart disease from partially overlapping meta-analyses of genotype-homocysteine and genotype-coronary heart disease associations),1,12 formal two-sample studies have been a more recent phenomenon. We therefore performed a literature search on 24 October 2016 in PubMed restricted to the period from 1 January 2011 to 24 October 2016 using the terms ‘Mendelian randomisation’ OR ‘Mendelian randomization’ to identify the proportion of Mendelian randomization papers using either the two-sample or subsample13 designs. As shown in Figure 1, the proportion rose from 0% in 2011 to 42% in 2016, with a marked increase since 2014. This suggests that two-sample Mendelian randomization already holds a prominent position in the Mendelian randomization literature and its relative importance is likely to continue to grow. Figure 1Scatter plots of all empirical Mendelian randomization studies in PubMed from 1 January 2011 to 24 October 2016. Left panel: absolute number of one-sample (dotted line) and subsample and/or two-sample Mendelian randomization studies (solid line). Right panel: proportion of subsample and/or two-sample Mendelian randomization studies (among all one-sample and subsample and/or two-sample studies). The dotted line indicates the 50% value. Even though the most natural application of summary data Mendelian randomization methods is in the two-sample setting (i.e. when instrument-exposure and instrument-outcome associations were estimated in non-overlapping sets of individuals), it is possible in principle to use summary data methods in the one-sample context – i.e. when instrument-exposure and instrument-outcome associations are estimated in the same sample. However, summary data Mendelian randomization analyses using instrument-exposure and instrument-outcome associations in the same sample or in partially overlapping samples may be prone to weak instrument bias towards the exposure-outcome estimate that would obtained using conventional methods (typically a regression of the outcome on the exposure). Therefore, using instrument-exposure and instrument-outcome associations estimated in non-overlapping samples is preferable.14 However, given that many two-sample Mendelian randomization applications use summary data from large GWAS consortia, it is possible that in many cases the instrument-exposure and instrument-outcome datasets partially overlap due to studies participating in both consortia; and detecting if this occurs and to what degree may depend on careful assessment of the description of the studies included in each consortium. The aims of this paper are to highlight the importance of harmonizing the genetic instrumental variables used for estimating the instrument-exposure and instrument-outcome associations, and to propose steps for doing this and checking the quality of the harmonization process in two-sample Mendelian randomization. GUIDELINES FOR PROPER HARMONIZATION OF DATASETS FOR TWO-SAMPLE MENDELIAN RANDOMIZATION APPLICATIONS In a paper recently published in the IJE, the general issue of data harmonization is discussed.15 Appropriate data harmonization is clearly essential when combining two or more independently generated datasets. This is particularly true for two-sample Mendelian randomization, because GWAS results rarely have harmonized effect (or coded) alleles. In genetic association studies, it is often assumed that genetic variants have additive (or per-allele) effects, which corresponds to coding the genotypes numerically according to the number of copies of one of the alleles. So, if a given variant was coded as AA = 0, AC = 1 and CC = 2 (i.e. according to the number of copies of the C allele), then C is termed the effect allele, and A the other (or non-coded, or baseline) allele. Table 1 provides an overview of the steps typically required to harmonize datasets of summary results of genetic associations for two-sample Mendelian randomization, based on the guidelines provided by Fortier and colleagues.15. Below, we will focus on two-sample Mendelian randomization using summary results from GWAS consortia. Table 1. Overview of the data harmonization process for two-sample Mendelian randomization applications, based on the guidelines provided by Fortier and colleagues15Harmonization stepProcedure in two-sample Mendelian randomization0) Define the research question, objectives and protocolPrior to data collection, define exposure(s) and outcome(s) variables, data analysis methods, targeted variables, etc. Targeted variables typically include an identifier of the genetic variant, effect and other alleles, effect allele frequency and regression coefficient and standard error1) Assemble pre-existing data sources and select datasetsIdentify potential sources of summary results (e.g. published reports, summary results from GWAS consortia or even individual-level data) and select the most appropriate ones given the research question2) Evaluate harmonization potential of the selected datasetsAt minimum, the effect allele must be available in all datasets to be harmonized. Additional variables, such as the other allelea and effect allele frequency, improve the harmonization potentialMissing exposure-associated variants in the variant-outcome dataset may be replaced by proxies available in the latterb but this reduces the quality of the harmonization processiii. Consider whether the populations used to generate the datasets are sufficiently similar to harmonize them3) Harmonize the dataIdentify variants that do not share the same allele pair between datasets, and either correct this if possiblec or eliminate such variants. Identify variants with unmatched effect and other alleles and ‘flip’ their effect estimatesd and effect allele frequenciesd in only one of the datasets4) Estimate quality of the harmonization processStrong correlation between effect allele frequencies before and after harmonization, low number of proxy variants used and strong linkage disequilibrium between proxy and index variants suggest good quality of the harmonization process5) Preserve and disseminate the final harmonized datasetsPublish the harmonized datasets (typically as supplementary material) with all the necessary information to allow replicating the analysis directly from the datasets provided and verifying the quality of the data harmonization processaKnowing the other allele is particularly useful for harmonization of palindromic variants.bVariants in high linkage disequilibrium with the index variant in the relevant ancestry group.cNot having the same allele pair could be a consequence of strand orientation

Read the complete text